Torrent Pharma Q1

Cons Net Profit At Rs 188 Cr Vs Rs 292 Cr (YoY)

Cons Revenue Down 11.4% At Rs 1,374 Cr (YoY);

Cons EBITDA Margin At 21.6% Vs 28.2% (YoY)